Fractional flow reserve at the crossroad between revascularization and medical therapy
- PMID: 30214877
- PMCID: PMC6129821
- DOI: 10.21037/cdt.2018.06.06
Fractional flow reserve at the crossroad between revascularization and medical therapy
Conflict of interest statement
Conflicts of Interest: C Collet reports receiving research grants from Heart Flow and Biosensors. PW Serruys is members of the International Advisory Board for Abbott Vascular.
Comment on
-
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).Circulation. 2018 Jan 30;137(5):480-487. doi: 10.1161/CIRCULATIONAHA.117.031907. Epub 2017 Nov 2. Circulation. 2018. PMID: 29097450 Clinical Trial.
References
-
- Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-67. 10.1161/01.CIR.87.4.1354 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources